Dramatically improved survival in multiple myeloma patients in the recent decade: results from a Swedish population-based study

Sigrun Thorsteinsdottir^{1

2}, Paul W Dickman³, Ola Landgren⁴, Cecilie Blimark⁵, Malin Hultcrantz^{4

6}, Ingemar Turesson⁷, Magnus Björkholm⁶, Sigurdur Y Kristinsson^{8

2

6}

Affiliations

¹ Department of Internal Medicine, Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland.
² Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
³ Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
⁴ Myeloma Service, Division of Hematologic Oncology, Memorial Sloan-Kettering Cancer Center, NY, USA.
⁵ Department of Internal Medicine, Hematology Section, Sahlgrenska University Hospital, Gothenburg, Sweden.
⁶ Department of Medicine, Division of Hematology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.
⁷ Department of Hematology and Coagulation Disorders, Skane University Hospital, Malmo, Sweden.
⁸ Department of Internal Medicine, Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland sigyngvi@hi.is.

Sigrun Thorsteinsdottir et al. Haematologica. 2018 Sep.

. 2018 Sep;103(9):e412-e415.

doi: 10.3324/haematol.2017.183475. Epub 2018 Mar 22.

Sigrun Thorsteinsdottir^{1

2}, Paul W Dickman³, Ola Landgren⁴, Cecilie Blimark⁵, Malin Hultcrantz^{4

6}, Ingemar Turesson⁷, Magnus Björkholm⁶, Sigurdur Y Kristinsson^{8

2

6}

¹ Department of Internal Medicine, Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland.
² Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
³ Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
⁴ Myeloma Service, Division of Hematologic Oncology, Memorial Sloan-Kettering Cancer Center, NY, USA.
⁵ Department of Internal Medicine, Hematology Section, Sahlgrenska University Hospital, Gothenburg, Sweden.
⁶ Department of Medicine, Division of Hematology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.
⁷ Department of Hematology and Coagulation Disorders, Skane University Hospital, Malmo, Sweden.
⁸ Department of Internal Medicine, Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland sigyngvi@hi.is.

No abstract available

Figures

1. Palumbo A, Anderson K. Multiple myeloma. N Engl J Med. 2011;364(11):1046–1060. - PubMed
1. Kristinsson SY, Landgren O, Dickman PW, et al. Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003. J Clin Oncol. 2007;25(15):1993–1999. - PubMed
1. Kristinsson SY, Anderson WF, Landgren O. Improved long-term survival in multiple myeloma up to the age of 80 years. Leukemia. 2014;28(6):1346–1348. - PubMed
1. Palumbo A, Rajkumar SV, San Miguel JF, et al. International Myeloma Working Group consensus statement for the management, treatment, and supportive care of patients with myeloma not eligible for standard autologous stem-cell transplantation. J Clin Oncol. 2014;32(6):587–600. - PMC - PubMed
1. Costa LJ, Hari PN, Kumar SK. Differences between unselected patients and participants in multiple myeloma clinical trials in US: a threat to external validity. Leuk Lymphoma. 2016;57(12):2827–2832. - PubMed